QualityMetric, an IQVIA business

QualityMetric is grateful for the opportunity to make a meaningful impact in the healthcare community. We appreciate our dedicated team, partners, clients, and the patients whose voices guide our work. Thank you for your continued support and collaboration in advancing patient-reported outcomes and improving healthcare quality.

QualityMetric is committed to supporting early detection and effective management of COPD through groundbreaking patient-reported outcome (PRO) measures like our COPD Population Screener™ (COPD-PS™). On World COPD Day, take the time to become familiar with this powerful tool for examining patient experiences and tailoring interventions to improve outcomes and quality of life: https://lnkd.in/gdrXj4Tx #WorldCOPDDay #COPD #PROmeasures

Today we raise awareness for millions of people living with diabetes. QualityMetric is proud to play a part in improving diabetes management and research through innovative patient-reported outcome (PRO) measures. Read more about our efforts to support diabetes care and how PRO measures are transforming the landscape of metabolic disorder research: https://lnkd.in/g4GDYh4B #WorldDiabetesDay #PatientReportedOutcomes #DiabetesAwareness

Data derived from real patient experiences using patient-reported outcome (PRO) measures can fill crucial knowledge gaps in clinical research and commercialization. Discover how PROs have become versatile instruments that enhance decision-making throughout the entire clinical trial. Visit to learn more: https://lnkd.in/gwkaX4fy #patientinsights #RWE #clinicaltrials

As healthcare systems face multiple epidemics of flu, pneumonia, respiratory syncytial virus (RSV) and COVID infections, the industry is racing to research and develop vaccines that can safeguard public health. Patient-reported outcome (PRO) measures can supplement vaccine research, development and impact analysis:https://lnkd.in/gWWUbNDF #PublicHealth #VaccineResearch #PROs

Enable an unbiased view of health outcomes and study results as a researcher or investigator. Find a patient-reported outcome assessment that fits your work in drug development: https://lnkd.in/gFVfh5Zp #exploratoryendpoints #regulatoryendpoints #clinicaltrials

COPD doesn’t just affect physical health—it can impact sleep, social functioning and emotional well-being. The COPD Population Screener™ (COPD-PS™) is a 5-item PRO survey that helps identify at-risk individuals by examining key domains such as shortness of breath, cough, sputum production and functional impact. Discover how the COPD-PS can transform your approach to COPD care: https://lnkd.in/gRiS8SAP #COPDAwarenessMonth #COAs #LungDisease

QualityMetric's science team consists of key thought leaders with decades of experience in patient outcome measures and clinical research. Take advantage of our expertise in varied qualitative and quantitative research designs and methods. Learn more about leveraging the knowledge of QM's scientific expertise for your research: https://lnkd.in/eCxucgfD

At QualityMetric, we’re committed to advancing patient-centered care through standard and disease-specific patient-reported outcome (PRO) measures. Our Transthyretin Amyloidosis Quality of Life Questionnaire (ATTR-QOL)—developed in partnership with the Amyloidosis Research Consortium (ARC) (ARC) is designed to illuminate the impact of amyloidosis on patients' daily lives, empowering healthcare providers and researchers to better understand and address their needs. Learn how the ATTR-QOL can contribute to better patient care: https://lnkd.in/g47iHuvg #WorldAmyloidosisDay #AmyloidosisResearch #PROMs

Children and adolescents can make accurate contributions to pediatric patient-reported outcome (PRO) surveys that have the potential to change the way we develop products, conduct research and deliver care. In a free guide, learn more about selecting and implementing pediatric PRO surveys to support health-related quality of life (HRQoL) measurement: https://lnkd.in/g4naPVJT #HRQoL #patientjourney #COAs